好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Botulinum-A Toxin Is Effective and Safe in the Treatment of Ultra-Short-Lasting Headaches and Trigeminal Neuralgias
105
Authors/Disclosures
Marissa Kellogg, MD, MPH, FAAN (VA Portland Healthcare System, Dept of Neurology) The institution of Dr. Kellogg has received research support from VA & DoD.
Zachary Kennedy No disclosure on file
No disclosure on file
No disclosure on file
Andrew Christiana, MD (NYU) Dr. Christiana has nothing to disclose.
Robert H. Brown, Jr., MD, DPhil (Univ of Massachusetts Medical School) Dr. Brown has received personal compensation for serving as an employee of ApicBio. Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ApicBio. Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Warren Alpert Foundation. Dr. Brown has stock in ApicBio. Dr. Brown has stock in Amylx. Dr. Brown has stock in Imstar. The institution of Dr. Brown has received research support from Angel Fund for ALS Research. The institution of Dr. Brown has received research support from ALS Association. The institution of Dr. Brown has received research support from ALSOne. The institution of Dr. Brown has received research support from NINDS. The institution of Dr. Brown has received research support from ALS Finding A Cure. Dr. Brown has received publishing royalties from a publication relating to health care.